2023-05-30 |
2023-05-25 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
50,000
+1.2%
1.72
86,000
USD
|
50,000
+1.2%
|
1.72
|
86,000
USD
|
|
2023-05-24 |
2023-05-22 |
S
Sale
|
GADICKE ANSBERT
Non-Executive Director
Large shareholder
|
70,170
-18.8%
1.88
131,920
USD
|
70,170
-18.8%
|
1.88
|
131,920
USD
|
|
2023-05-24 |
2023-05-22 |
S
Sale
|
MPM ASSET MANAGEMENT LLC
Large shareholder
|
70,170
-18.8%
1.88
131,920
USD
|
70,170
-18.8%
|
1.88
|
131,920
USD
|
|
2023-05-15 |
2023-05-12 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
6,183
+0.1%
1.95
12,057
USD
|
6,183
+0.1%
|
1.95
|
12,057
USD
|
|
2023-05-15 |
2023-05-11 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
38,765
+0.9%
1.95
75,592
USD
|
38,765
+0.9%
|
1.95
|
75,592
USD
|
|
2023-05-10 |
2023-05-10 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
6,774
+0.2%
1.95
13,209
USD
|
6,774
+0.2%
|
1.95
|
13,209
USD
|
|
2023-05-10 |
2023-05-09 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
20,141
+0.5%
1.95
39,275
USD
|
20,141
+0.5%
|
1.95
|
39,275
USD
|
|
2023-05-10 |
2023-05-08 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
57,073
+1.4%
1.95
111,292
USD
|
57,073
+1.4%
|
1.95
|
111,292
USD
|
|
2023-05-05 |
2023-05-05 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
71,064
+1.7%
1.94
137,864
USD
|
71,064
+1.7%
|
1.94
|
137,864
USD
|
|
2023-05-05 |
2023-05-05 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
95,759
+2.4%
1.90
181,942
USD
|
95,759
+2.4%
|
1.90
|
181,942
USD
|
|
2023-05-05 |
2023-05-04 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
104,241
+2.6%
1.86
193,888
USD
|
104,241
+2.6%
|
1.86
|
193,888
USD
|
|
2023-05-05 |
2023-05-03 |
B
Purchase
|
TANG KEVIN C
Large shareholder
|
18,513
+0.5%
1.85
34,249
USD
|
18,513
+0.5%
|
1.85
|
34,249
USD
|
|
2022-12-13 |
2022-12-13 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,659
-6.4%
1.07
1,767
USD
|
1,659
-6.4%
|
1.07
|
1,767
USD
|
|
2022-12-13 |
2022-12-13 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
11,000
-7.3%
1.06
11,682
USD
|
11,000
-7.3%
|
1.06
|
11,682
USD
|
|
2022-12-13 |
2022-12-13 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,752
-4.2%
1.06
5,042
USD
|
4,752
-4.2%
|
1.06
|
5,042
USD
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,610
-5.9%
1.10
1,766
USD
|
1,610
-5.9%
|
1.10
|
1,766
USD
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
10,613
-6.6%
1.10
11,674
USD
|
10,613
-6.6%
|
1.10
|
11,674
USD
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,963
-5.7%
1.06
3,150
USD
|
2,963
-5.7%
|
1.06
|
3,150
USD
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,865
-5.2%
1.10
3,149
USD
|
2,865
-5.2%
|
1.10
|
3,149
USD
|
|
2022-12-13 |
2022-12-12 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,586
-3.9%
1.10
5,040
USD
|
4,586
-3.9%
|
1.10
|
5,040
USD
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,561
-5.4%
1.13
1,765
USD
|
1,561
-5.4%
|
1.13
|
1,765
USD
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
10,325
-6.0%
1.13
11,678
USD
|
10,325
-6.0%
|
1.13
|
11,678
USD
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,792
-4.9%
1.13
3,149
USD
|
2,792
-4.9%
|
1.13
|
3,149
USD
|
|
2022-12-13 |
2022-12-09 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,461
-3.6%
1.13
5,041
USD
|
4,461
-3.6%
|
1.13
|
5,041
USD
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
4,014
-3.2%
1.26
5,042
USD
|
4,014
-3.2%
|
1.26
|
5,042
USD
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,511
-4.2%
1.26
3,151
USD
|
2,511
-4.2%
|
1.26
|
3,151
USD
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
9,314
-5.2%
1.25
11,680
USD
|
9,314
-5.2%
|
1.25
|
11,680
USD
|
|
2022-12-09 |
2022-12-08 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,410
-4.6%
1.25
1,767
USD
|
1,410
-4.6%
|
1.25
|
1,767
USD
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,928
-3.0%
1.28
5,040
USD
|
3,928
-3.0%
|
1.28
|
5,040
USD
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,457
-3.9%
1.28
3,150
USD
|
2,457
-3.9%
|
1.28
|
3,150
USD
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
9,111
-4.8%
1.28
11,680
USD
|
9,111
-4.8%
|
1.28
|
11,680
USD
|
|
2022-12-09 |
2022-12-07 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,378
-4.3%
1.28
1,767
USD
|
1,378
-4.3%
|
1.28
|
1,767
USD
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,361
-3.6%
1.33
3,150
USD
|
2,361
-3.6%
|
1.33
|
3,150
USD
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,327
-4.0%
1.33
1,765
USD
|
1,327
-4.0%
|
1.33
|
1,765
USD
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,778
-2.8%
1.33
5,040
USD
|
3,778
-2.8%
|
1.33
|
5,040
USD
|
|
2022-12-07 |
2022-12-06 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
14,886
-7.3%
1.35
20,081
USD
|
14,886
-7.3%
|
1.35
|
20,081
USD
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,302
-3.4%
1.37
3,161
USD
|
2,302
-3.4%
|
1.37
|
3,161
USD
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,291
-3.8%
1.37
1,766
USD
|
1,291
-3.8%
|
1.37
|
1,766
USD
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,686
-2.7%
1.37
5,050
USD
|
3,686
-2.7%
|
1.37
|
5,050
USD
|
|
2022-12-07 |
2022-12-05 |
PS
Planned sale
|
Menzel Garry E
President and CEO
Executive Director
|
8,530
-4.0%
1.37
11,703
USD
|
8,530
-4.0%
|
1.37
|
11,703
USD
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Justice Angela
Chief People Officer
Officer
|
2,273
-3.3%
1.39
3,162
USD
|
2,273
-3.3%
|
1.39
|
3,162
USD
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Olagunju Peter
Chief Technical Officer
Officer
|
1,273
-3.6%
1.39
1,766
USD
|
1,273
-3.6%
|
1.39
|
1,766
USD
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Menzel Garry E
President & CEO
Executive Director
|
8,408
-3.8%
1.39
11,687
USD
|
8,408
-3.8%
|
1.39
|
11,687
USD
|
|
2022-12-05 |
2022-12-02 |
PS
Planned sale
|
Cardama Alfonso Quintas
Chief Medical Officer
Officer
|
3,636
-2.6%
1.39
5,054
USD
|
3,636
-2.6%
|
1.39
|
5,054
USD
|
|
2020-12-16 |
2020-12-14 |
PS
Planned sale
|
Somaiya Mayur Ian
Chief Financial Officer
Officer
|
2,000
-57.6%
35.00
70,000
USD
|
2,000
-57.6%
|
35.00
|
70,000
USD
|
|
2020-11-19 |
2020-11-17 |
PS
Planned sale
|
Somaiya Mayur Ian
Chief Financial Officer
Officer
|
1,666
-53.1%
30.00
49,980
USD
|
1,666
-53.1%
|
30.00
|
49,980
USD
|
|
2020-11-19 |
2020-11-17 |
PS
Planned sale
|
Somaiya Mayur Ian
Chief Financial Officer
Officer
|
2,000
-38.9%
30.00
60,000
USD
|
2,000
-38.9%
|
30.00
|
60,000
USD
|
|
2020-11-13 |
2020-11-12 |
PS
Planned sale
|
Hofmeister Robert
Chief Scientific Officer
Officer
|
10,002
-20.5%
25.10
251,050
USD
|
10,002
-20.5%
|
25.10
|
251,050
USD
|
|
2020-11-13 |
2020-11-12 |
PS
Planned sale
|
Hofmeister Robert
Chief Scientific Officer
Officer
|
9,998
-20.5%
25.10
250,950
USD
|
9,998
-20.5%
|
25.10
|
250,950
USD
|
|
2020-11-02 |
2020-10-29 |
PS
Planned sale
|
Hofmeister Robert
Chief Science Officer
Officer
|
20,000
-34.0%
19.10
382,000
USD
|
20,000
-34.0%
|
19.10
|
382,000
USD
|
|
2020-03-27 |
2020-03-20 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
648
-100.0%
7.94
5,145
USD
|
648
-100.0%
|
7.94
|
5,145
USD
|
|
2020-03-27 |
2020-03-19 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
3,140
-82.9%
7.41
23,267
USD
|
3,140
-82.9%
|
7.41
|
23,267
USD
|
|
2020-03-27 |
2020-03-18 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
3,120
-45.2%
6.83
21,310
USD
|
3,120
-45.2%
|
6.83
|
21,310
USD
|
|
2020-03-27 |
2020-03-17 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
3,009
-30.3%
6.49
19,528
USD
|
3,009
-30.3%
|
6.49
|
19,528
USD
|
|
2020-03-27 |
2020-03-16 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
17,723
-64.1%
6.60
117,043
USD
|
17,723
-64.1%
|
6.60
|
117,043
USD
|
|
2020-03-27 |
2020-03-13 |
S
Sale
|
Gibson Neil W
Non-Executive Director
|
52,000
-65.3%
6.52
338,894
USD
|
52,000
-65.3%
|
6.52
|
338,894
USD
|
|
2019-12-26 |
2019-12-23 |
PS
Planned sale
|
Baeuerle Patrick
Non-Executive Director
|
84,907
-19.5%
15.44
1,310,964
USD
|
84,907
-19.5%
|
15.44
|
1,310,964
USD
|
|
2019-12-26 |
2019-12-20 |
PS
Planned sale
|
Baeuerle Patrick
Non-Executive Director
|
32,022
-6.8%
15.16
485,454
USD
|
32,022
-6.8%
|
15.16
|
485,454
USD
|
|
2019-12-20 |
2019-12-19 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
35,323
-18.5%
16.47
581,819
USD
|
35,323
-18.5%
|
16.47
|
581,819
USD
|
|
2019-12-20 |
2019-12-19 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
6,642
-7.4%
16.47
109,403
USD
|
6,642
-7.4%
|
16.47
|
109,403
USD
|
|
2019-12-20 |
2019-12-18 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
2,433
-1.3%
17.01
41,376
USD
|
2,433
-1.3%
|
17.01
|
41,376
USD
|
|
2019-12-20 |
2019-12-18 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
458
-0.5%
17.01
7,789
USD
|
458
-0.5%
|
17.01
|
7,789
USD
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
4,153
-0.3%
17.65
73,311
USD
|
4,153
-0.3%
|
17.65
|
73,311
USD
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
1,054
-0.3%
17.65
18,606
USD
|
1,054
-0.3%
|
17.65
|
18,606
USD
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
1,381
-0.3%
17.65
24,378
USD
|
1,381
-0.3%
|
17.65
|
24,378
USD
|
|
2019-12-11 |
2019-12-11 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
1,155
-0.3%
17.65
20,389
USD
|
1,155
-0.3%
|
17.65
|
20,389
USD
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
30,475
-2.3%
17.62
537,067
USD
|
30,475
-2.3%
|
17.62
|
537,067
USD
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
7,741
-2.3%
17.62
136,421
USD
|
7,741
-2.3%
|
17.62
|
136,421
USD
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
10,135
-2.3%
17.62
178,611
USD
|
10,135
-2.3%
|
17.62
|
178,611
USD
|
|
2019-12-11 |
2019-12-10 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
8,479
-2.3%
17.62
149,427
USD
|
8,479
-2.3%
|
17.62
|
149,427
USD
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
75,067
-5.3%
17.65
1,325,015
USD
|
75,067
-5.3%
|
17.65
|
1,325,015
USD
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
19,070
-5.3%
17.65
336,606
USD
|
19,070
-5.3%
|
17.65
|
336,606
USD
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
24,966
-5.3%
17.65
440,677
USD
|
24,966
-5.3%
|
17.65
|
440,677
USD
|
|
2019-12-11 |
2019-12-09 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
20,886
-5.3%
17.65
368,661
USD
|
20,886
-5.3%
|
17.65
|
368,661
USD
|
|
2019-10-24 |
2019-10-22 |
S
Sale
|
Jovan-Embiricos Morana
Large shareholder
|
2,085
-0.1%
15.16
31,603
USD
|
2,085
-0.1%
|
15.16
|
31,603
USD
|
|